| Income Statement |
| Total Revenue | 2.71B |
|
| Revenues (USD) | 2.71B |
| Cost of Revenue | 1.03B |
| Gross Profit | 1.68B |
| Operating Expenses | 519.00M |
| Research and Development Expense | 343.70M |
| Selling, General and Administrative Expense | 175.30M |
| Operating Income | 1.16B |
| Income Tax Expense | 248.50M |
| Net Income | 1.02B |
| Net Income Common Stock | 1.02B |
| Net Income Common Stock (USD) | 1.02B |
| Consolidated Income | 1.02B |
| Earnings per Basic Share | 0.81 |
| Earnings per Basic Share (USD) | 0.81 |
| Earnings per Diluted Share | 0.80 |
| Earning Before Interest & Taxes (EBIT) | 1.27B |
| Earning Before Interest & Taxes (USD) | 1.27B |
| Weighted Average Shares | 1.26B |
| Weighted Average Shares Diluted | 1.27B |
| Balance Sheet |
| Cash and Equivalents | 2.79B |
| Cash and Equivalents (USD) | 2.79B |
| Investments | 9.56B |
| Investments Current | 9.56B |
| Trade and Non-Trade Receivables | 1.92B |
| Current Assets | 18.56B |
| Property, Plant & Equipment Net | 250.30M |
| Total Assets | 21.66B |
| Current Liabilities | 6.56B |
| Total Liabilities | 8.17B |
| Accumulated Retained Earnings (Deficit) | 10.47B |
| Accumulated Other Comprehensive Income | -19.30M |
| Shareholders Equity | 13.49B |
| Shareholders Equity (USD) | 13.49B |
| Assets Non-Current | 3.10B |
| Deferred Revenue | 6.20B |
| Goodwill and Intangible Assets | 416.10M |
| Inventory | 2.38B |
| Liabilities Non-Current | 1.61B |
| Trade and Non-Trade Payables | 608.40M |
| Tax Assets | 1.89B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 23.30M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 825.60M |
| Capital Expenditure | -54.50M |
| Issuance (Purchase) of Equity Shares | 29.90M |
| Net Cash Flow from Investing | -865.30M |
| Net Cash Flow - Investment Acquisitions and Disposals | -815.80M |
| Net Cash Flow from Operations | 1.69B |
| Effect of Exchange Rate Changes on Cash | -2.60M |
| Share Based Compensation | 120.90M |